Semaglutide is effective in type 2 diabetes and obesity with schizophrenia

被引：0
|
作者：
Kaoru Noda
Takehiro Kato
Nao Nomura
Mayu Sakai
Sodai Kubota
Tokuyuki Hirose
Yanyan Liu
Yoshihiro Takahashi
Ken Takao
Masami Mizuno
Takuo Hirota
Tetsuya Suwa
Yukio Horikawa
Daisuke Yabe
机构：
[1] Gifu University Graduate School of Medicine,Department of Diabetes, Endocrinology and Metabolism
[2] Gifu University Graduate School of Medicine,Department of Rheumatology and Clinical Immunology
[3] Kansai Electric Power Medical Research Institute,Yutaka Seino Distinguished Center for Diabetes Research
[4] Tokai National Higher Education and Research System,Center for Healthcare Information Technology
[5] Kobe University Graduate School of Medicine,Division of Molecular and Metabolic Medicine
来源：
Diabetology International | 2022年 / 13卷
关键词：
GLP-1 receptor agonist; Schizophrenia; Obesity; Type 2 diabetes; Bodyweight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 697
页数：4
相关论文
共 50 条
  • [41] Obesity and type 2 diabetes
    Shulman, ST
    PEDIATRIC ANNALS, 2005, 34 (09): : 668 - 668
  • [42] Type 2 diabetes in obesity
    Chakaroun, R.
    DIABETOLOGE, 2014, 10 (07): : 581 - 582
  • [43] Obesity and type 2 diabetes
    Waine, C.
    NUTRITION BULLETIN, 2006, 31 (02) : 111 - 114
  • [44] Obesity and type 2 diabetes
    Toplak, Hermann
    Hoppichler, Friedrich
    Wascher, Thomas C.
    Schindler, Karin
    Ludvik, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S196 - S200
  • [45] SEMAGLUTIDE DAMPENS RESIDUAL INFLAMMATION IN INDIVIDUALS WITH TYPE 2 DIABETES
    Oostveen, Reindert
    Teunis, Charlotte
    Tzolos, Evangelos
    Kroon, Jeffrey
    Verberne, Hein
    Murphy, Andrew
    Stroes, Erik
    Hanssen, Nordin
    ATHEROSCLEROSIS, 2024, 395
  • [46] Glycaemic control and weight loss with semaglutide in type 2 diabetes
    Madsbad, Sten
    Holst, Jens J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 315 - +
  • [47] Comparison of different doses of tirzepatide and semaglutide in type 2 diabetes
    Kahl, S.
    DIABETOLOGIE, 2022, 18 (06): : 756 - 757
  • [48] The Effects of Semaglutide on β-cell Function in Subjects with Type 2 Diabetes
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob Bonde
    Axelsen, Mads Buhl
    Flint, Anne
    DIABETES, 2016, 65 : A262 - A263
  • [49] Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus
    Semenya, Afi Mansa
    Wilson, Stephen A.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (10) : 627 - 628
  • [50] Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes
    Goldenberg, Ronald M.
    Steen, Oren
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (02) : 136 - 145
12345